Product Images Varenicline

Each film-coated tablet contains 0.85 mg varenicline tartrate equivalent to 0.5 mg varenicline free base. The tablets are stored at a temperature range of 68°F to 77°F with excursions permitted at 59°F to 86°F. They should be dispensed in tight, child-resistant containers and kept out of reach of children. The accompanying prescribing information should be consulted before use.*

This is a medication schedule outlining the dosage and timing for taking Varenicline tablets. It specifies taking one tablet in the morning and one in the evening for specified days (Day 22-28, Day 15-21, Day 8-14, and Day 1-7) as part of a continuing week. It also mentions the tablet strength as 1mg.*

This text provides detailed information about Varenicline tablets in two different strengths: 0.5 mg and 1 mg. Each tablet contains varenicline tartrate equivalent to the specified free base amount. The text includes dosage instructions and advises referring to the Medication Guide for further details. The tablets should be stored within a certain temperature range. The product is marketed by Ajanta Pharma USA Inc. and manufactured in India. It also includes codes for identification purposes.*

This is a medication schedule for Varenicline tablets. The tablets are classified by their dosage strength (0.5 mg or 1 mg) and the specific days when they should be consumed. The schedule specifies taking one tablet in the morning and one in the evening on certain days. It starts with the Starting Week, then continues with three subsequent Continuing Weeks. The purpose of this schedule is likely to outline a gradual dosing regimen for the medication.*

This is a chart showing the Continuous Abstinence Rate during Nontreatment Follow-Up for two groups, one taking Varenicline Tablet 10mg and the other taking Placebo. The percentage of participants who remained continuously abstinent from smoking is plotted over the course of several weeks of nontreatment follow-up. Time is measured in weeks along the X-axis and the percentage of continuous abstinent participants is shown on the Y-axis.*